The Center for Technology Licensing's (CTL) mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation.
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world in support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Available Cornell Technologies
- Raspberry 'Crimson Treasure'
- Multiplex Diagnostic Test for Equine Herpes Virus Type 1
- Treatment of Cardiac Disorder with Nicotinamide Riboside
- Use of a single massively multiplex digital PCR assay for minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) patients
- Novel Annexin A2 Antibodies as Therapeutics for Diabetic Retinopathy and Proliferative Vitreoretinopathy
- Use of Tumor-derived Exomeres as a Novel Biomarker in Cancer Detection
Current Featured Technologies
- » Generic Programmable Tag
- » Biomarkers for Predicting & Diagnosing Cancer/Metastasis
- » Accommodating Intraocular Lens & Conversion Plate
- » Red Wine Grape ‘Arandell’
- » White Wine Grape ‘Aromella’
- » Tethered Enzyme Technology (TET™) Point-of-Care Testing for Brain Injuries
- » Reversible Small Molecule Immunoproteasome Inhibitors